Medtronic gets US FDA nod for use of MiniMed 670G system patients with type 1 diabetes seven years of age and older

Medtronic plc, the global leader in medical technology, announced that the US Food and Drug Administration (FDA) has approved the use of the MiniMed 670G system in patients with type 1 diabetes seven years of age

More From BioPortfolio on "Medtronic gets US FDA nod for use of MiniMed 670G system patients with type 1 diabetes seven years of age and older"